Authors
Loading...
Diagnostic study demonstrates enhanced tumor detection from combined PIVKA-II, GGT-II, and AFP in liver disease, suggesting improved diagnostic sensitivity for hepatocellular carcinoma.
Cui et al. (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: